CY71 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anixa Biosciences Inc

Watchlist Manager

Watchlist

Price: 3.01 EUR -1.47% Market Closed

Market Cap: €96.4m

A	Anixa Biosciences Inc F:CY71	US
A	Apple iSports Group Inc OTC:AAPI	AU
	Ibio Inc F:0JV	US
	Coca-Cola Bottlers Japan Holdings Inc F:CCW	JP
	James Halstead PLC F:HSJA	UK
M	Mycenax Biotech Inc TPEX:4726	TW
A	Allied Circuit Co Ltd TPEX:8155	TW
	Hokkaido Electric Power Co Inc OTC:HKEPF	JP
C	Citigroup Inc XHAN:TRVC	US
	Masi Agricola SpA F:0CY	IT

Profitability Summary

Anixa Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-5.448%

Low Net Margin

Negative 3Y Average Net Margin

-4.945%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-2.947%

Negative ROE

-66%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.221%

ROIC is Increasing

-1.409% > -1.055%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.